Frequently Asked Questions – Clinical Use & Safety

How does Opto support clinical teams?

Opto provides a structured starting point before first contact:

• Early risk flagging and visibility of acuity
• Consistent capture of key clinical indicators
• A concise, readable summary alongside full response detail
• Reduced time spent on basic history gathering at the front door
• Immediate streaming to the most appropriate area

How are high-risk patients identified?

Rules-based logic identifies key indicators (e.g. stroke symptoms, sepsis indicators, safeguarding concerns). These are clearly flagged and escalated for immediate review. The logic is transparent and clinically governed.

How are patients prioritised?

Patients are assigned a priority score (e.g. P1–P5) based on responses and configured pathways. This supports early visibility of acuity and helps teams meet rapid initial assessment expectations.

What if the triage outcome looks incorrect?

Clinicians can review, override, and amend any outcome at any time. Opto does not constrain clinical decision-making.

Is Opto clinically safe?

Yes. Opto is developed and maintained in line with DCB0129 with:

• A maintained Clinical Safety Case Report
• A Hazard Log with defined mitigations
• Ongoing clinical governance and oversight
• Continuous monitoring and improvement based on real-world use